National Human Genome Sciences Institute today launched a multi-center initiative to research how variations in DNA sequences confer disease risks.
A Nature paper today discusses findings from sequencing and data analysis of 53,581 diverse human genomes.
Sequencing expert Deborah Nickerson, from UW Medicine Genome Sciences and Brotman Baty Institute for Precision Medicine, explains initial findings.
Drug response screening of leukemia stem cells offers clues to relapse and suggests ways to improve patient-specific therapies.
Your genes could help lead to better care for a patient in the future.
It was a big day for UW Medicine, Fred Hutchinson Cancer Research Center, and other local medical science leaders at GeekWire Summit 2018, a Seattle present-meets-future technology conference.
Upfront tumor DNA sequencing might simultaneously provide both better detection sensitivity than standard tests, and critical information for treatment.
Dr. Tony Blau founded All4Cure, an online knowledge-sharing website for doctors, researchers and patients with multiple myeloma, a cancer of the plasma cells.
Greg Ledwon, a patient with acute myeloid leukemia says he is slaying cancer and is excited about the prospects of curing leukemia.
UW Medicine genome scientist Jay Shendure describes precision medicine -- that is, the idea that cell-based research might revolutionize medical care, yielding therapies personalized to individual patients.